Neuronal Signaling

Scope:

Neuronal Signaling: from cell to brain.

The mission of Neuronal Signaling is to provide an interdisciplinary home for neuroscience covering all aspects of in vitro and in vivo signaling from cell to brain in health and disease. Relevant topics range from signaling pathways involved in nervous system development and normal physiology through to neurodegenerative, neurological and psychiatric disorders and other pathologies.
 
Neuronal Signaling is a peer-reviewed, open access journal and is a home for research and reviews on molecular and cellular neuroscience, supported by Editor-in-Chief Clare Stanford and an expert Editorial Board. Neuronal Signaling is published by Portland Press on behalf of the Biochemical Society. The Biochemical Society is the UK’s largest single-discipline learned society, promoting the advancement of molecular bioscience; Portland Press is the publishing arm of the Biochemical Society, with all profits being returned to the Society for them to carry out their charitable endeavours.

Neuronal Signaling is indexed in PubMed Central, Google Scholar and the Directory of Open Access Journals (DOAJ). 
 
The journal’s interdisciplinary scope includes (but is not limited to) basic signaling mechanisms (e.g. neurotransmitters, ions and ion channels, receptors and messenger molecules, molecular genetics and epigenetic mechanisms), as well as electrical signaling, signaling in neural circuits (including neuroimaging), signaling aspects of pathologies, synaptic transmission and plasticity, and therapeutic intervention. 
 

The Journal covers a number of areas of neuroscience, including (but not limited to): 

Addiction, affective disorders and depression, aging, cellular and molecular mechanisms of behaviour, cognition, epilepsy, gene therapy, learning and memory, neurodegeneration, neuroendocrinology, neurogenesis, neuroimmunology, neurooncology, neuropharmacology and therapeutics, neurotoxicity, pain and analgesia, psychiatric disorders, stress and fear, stroke and cerebrovascular disease, technical developments and methodologies in neuroscience research.

Benefits of publishing in Neuronal Signaling

• Improved article discoverability and continued integration with Google Scholar and indexed in PubMed Central and DOAJ
• Open access - ensuring that you are compliant with your funder mandates
• Open access fee discounts to Biochemical Society members and authors at subscribing institutions, plus waivers of discounts for authors from low-income countries
• Find out if you can publish open access for free through the Biochemical Society/Portland Press Read & Publish offerings, where authors based at participating institutions can publish open access in any of our journals with no author-facing article publishing charges (APCs) and have read access to our published content.
• No subscription or page charges
• No charge for colour figures
• Rigorous peer-review process and a simple submission process
• Compliant with COPE and ICMJE guidelines

Editor-in-Chief

Professor Clare Stanford (University College London, UK). Please view the full Editorial Board for Neuronal Signaling here.

Open Access information

Neuronal Signalling is a fully open access journal, publishing online only. Every article carries a Gold open access Article Publishing Charge (APC) and all articles are published under a Creative Commons CC BY licence. For further information regarding our open access policy, APCs, the CC BY licence and waivers for APCs, please follow this link. Waivers for APCs are available for authors from some countries.

For further information regarding submitting an article to Neuronal Signaling, please see our full Submission Guidelines and Editorial Policy. Alternatively, you can contact the Editorial Team at editorial@portlandpress.com with any questions.